Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Heartbeam Inc
(NQ:
BEAT
)
3.800
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 2, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
183
Open
3.800
Bid (Size)
3.810 (4)
Ask (Size)
3.900 (5)
Prev. Close
3.800
Today's Range
3.800 - 3.800
52wk Range
1.120 - 6.740
Shares Outstanding
34,260,799
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Names Senior Medical Tech Veteran as New President
January 24, 2023
Via
Investor Brand Network
HeartBeam Appoints Robert Eno as President
January 24, 2023
From
HeartBeam, Inc.
Via
Business Wire
Performance
YTD
-17.39%
-17.39%
1 Month
-17.39%
-17.39%
3 Month
+7.04%
+7.04%
6 Month
+167.61%
+167.61%
1 Year
+85.37%
+85.37%
More News
Read More
HeartBeam Inc. (NASDAQ: BEAT) Combats Rising Heart Disease Numbers by Leading Out in Heart-Attack Detection Space
January 24, 2023
Via
Investor Brand Network
BioMedNewsBreaks – HeartBeam Inc.’s (NASDAQ: BEAT) Growing Patent Portfolio Poised to Have Disruptive Effect on Multibillion Markets
January 19, 2023
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) CEO Featured in Traders News Source Interview
January 12, 2023
Via
Investor Brand Network
CEO & Founder of Heartbeam Inc. Discusses the Potential for the AIMI(TM) and AIMIGo(TM) Technology in an Audio Interview with TradersNewsSource.com
January 12, 2023
Via
ACCESSWIRE
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Receives Key Patent from European Patent Office
January 05, 2023
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
HeartBeam Granted European Patent for Signal Transformation from Vector Electrocardiogram (VECG) to 12-Lead Electrocardiogram (ECG)
January 05, 2023
From
HeartBeam, Inc.
Via
Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Releases Shareholder Letter, Including Corporate Update
December 29, 2022
Via
Investor Brand Network
Exposures
Product Safety
HeartBeam Issues Shareholder Letter and Provides Corporate Update
December 29, 2022
From
HeartBeam, Inc.
Via
Business Wire
HeartBeam Inc. (NASDAQ: BEAT) CEO Featured Guest on Big Biz Show, Talks ‘Breakthrough’ Heart-Attack Detection Technology
December 21, 2022
Via
Investor Brand Network
HeartBeam (NASDAQ: BEAT) Looks to Disrupt to Multi-Billion-Dollar Patch Market with its Patent-Protected 12-Lead ECG Patch Product
December 20, 2022
Via
News Direct
HeartBeam Inc. (NASDAQ: BEAT) Granted Patent for Proprietary ECG Smartwatch-Based Monitor Designed for Heart Attack Detection
December 19, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Adds Renowned Cardiologist to Help Define Best Paths to Advance Products
December 16, 2022
Via
Investor Brand Network
HeartBeam (NASDAQ: BEAT) Looks to Disrupt Multi-Billion-Dollar Patch Market with its Patent-Protected 12-Lead ECG Patch Product
December 15, 2022
Via
Benzinga
HeartBeam (NASDAQ: BEAT) Stands to Disrupt to Multi-Billion-Dollar Patch Market with its Patent-Protected 12-Lead ECG Patch Product
December 15, 2022
Via
Spotlight Growth
HeartBeam (NASDAQ: BEAT): Innovative Technologies Disrupting the Old Standard of Care for Heart Patients and Upgrading ECG for the 21st Century
December 08, 2022
Via
Spotlight Growth
Topics
Death
Exposures
Death
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Signs Agreement to Build Exclusive AIMIGo 12-Lead 3D VECG Device
December 07, 2022
Via
Investor Brand Network
Topics
Supply Chain
Exposures
Product Safety
Supply Chain
HeartBeam (NASDAQ: BEAT) Partners with Evolve Manufacturing to Build HeartBeam AIMIGoTM 12-Lead 3D Vector Electrocardiogram Device
December 07, 2022
Via
Spotlight Growth
Topics
Supply Chain
Exposures
Product Safety
Supply Chain
HeartBeam Partners with Evolve Manufacturing to Build HeartBeam AIMIGoTM 12-Lead 3D Vector Electrocardiogram Device
December 07, 2022
From
HeartBeam, Inc.
Via
Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Recognized for ‘Unique Approach to Heart Attack Diagnosis’
December 02, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Benzinga's Top Ratings Upgrades, Downgrades For December 2, 2022
December 02, 2022
Via
Benzinga
HeartBeam Inc. (NASDAQ: BEAT) Announces New Chief Medical Officer
November 23, 2022
Via
Investor Brand Network
HeartBeam Inc. (NASDAQ: BEAT) Awarded Top Honors for Game-Changing Cardiovascular Tech Platform
November 21, 2022
Via
Investor Brand Network
Why Drive Shack Shares Jumped Over 23%; Here Are 76 Biggest Movers From Yesterday
November 22, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.